why choose us

First received: February 20, 2025

Clinical Trial: A Pilot Study of Curcumin (Soloways ™) in Patients with Inflammatory Bowel Disease Homozygous for the IL-10 Variant

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Inflamatory Bowel Disease (Crohn's and Ulcerative Colitis)

Study Type: INTERVENTIONAL


Official Title: A Pilot Study of Curcumin (Soloways ™) in Patients with Inflammatory Bowel Disease Homozygous for the IL-10 Variant

Brief Summary: This pilot, genotype-stratified clinical trial aims to evaluate the safety and preliminary efficacy of liposomal curcumin in patients with inflammatory bowel disease (IBD) who are homozygous for a specific "unfavorable" IL-10 gene variant (e.g., rs1800896).The study will compare clinical and inflammatory markers in two cohorts: (1) homozygous carriers of the IL-10 variant and (2) non- carriers.The hypothesis is that curcumin supplementation will lead to more pronounced improvement in clinical activity…

Read more